Umedica Laboratories Private Limited, a active private limited company, was established on 05 January 1982 in Pardi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1982PTC141202. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹17.50 Cr and a paid-up capital of ₹3.60 Cr.
Formerly known as Umedica Laboratories Limited. It upholds a compliant status. Employing 869 professional, Its leadership includes Manish Umed Doshi (Managing Director), Rupesh Suryakant Kamdar (Director), Vandana Manish Doshi (Director). Past directors included Induben Umed Doshi, Manish Umed Doshi, Rupesh Suryakant Kamdar. It holds ₹531.86 Cr open charges and ₹188.81 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at P. No-221,222/1, Gidc, Vapi, Pardi, Gujarat, 396191.
U24231GJ1982PTC141202
141202
05 January 1982
₹17.50 Cr
₹3.60 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Umedica Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Umed Doshi | Managing Director | 05 Jan 1982 | Current |
| Rupesh Suryakant Kamdar | Director | 02 Aug 2018 | Current |
| Vandana Manish Doshi | Director | 17 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Apr 2017 | Past |
| Pramod Abcsdd | Director | 26 Feb 2025 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Umedica Laboratories Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 1.46% decrease. The company also saw a substantial improvement in profitability, with a 148.35% increase in profit. The company's net worth moved up by a moderate rise of 6.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Umedica Laboratories had a promoter holding of 88.79% and a public holding of 11.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,318,600,000.00
₹1,888,071,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2022 | Hdfc Bank Limited | ₹15.00 Cr | Open |
| 10 Feb 2022 | State Bank Of India | ₹30.00 Cr | Open |
| 01 Nov 2021 | Sbicap Trustee Company Limited | ₹77.89 Cr | Open |
| 28 Oct 2021 | Sbicap Trustee Company Limited | ₹132.69 Cr | Open |
| 28 Oct 2021 | Sbicap Trustee Company Limited | ₹216.58 Cr | Open |
Explore comprehensive loan charge details -
Umedica Laboratories has a workforce of 869 employees as of Jan 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Umedica Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umedica Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 18 May 2020 via Charge ID 100346851 with Others was fully satisfied on 20 Jun 2025. was documented.
The activity A charge registered on 14 May 2019 via Charge ID 100261751 with Others was fully satisfied on 02 Apr 2025. was completed.
Heenal Pankaj Shah was appointed as a Company Secretary was appointed as a Company Secretary on 30 Jan 2025 & has been associated with this company since 10 months . was recorded as a recent event.
Umedica Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Umedica Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
A charge with Sbicap Trustee Company Limited of Rs. 132.69 Cr registered on 28 Oct 2021 with Charge ID 100497172 was modified on 23 Mar 2023. was recorded as a recent event.
CDSCO plans to rope in state drug control organizations to look into the issues raised by Vietnam over the quality of drugs from India.
The CIN of Umedica Laboratories Private Limited is U24231GJ1982PTC141202.
Umedica Laboratories Private Limited is headquartered at P. No-221,222/1, Gidc, Vapi, Pardi, Gujarat, 396191.
Umedica Laboratories Private Limited was incorporated on 05 January 1982.
The current directors of Umedica Laboratories Private Limited are
The primary industry of Umedica Laboratories Private Limited is Manufacturing.
Umedica Laboratories Private Limited is unlisted.
The authorized capital of Umedica Laboratories Private Limited is ₹17.50 Cr, and the paid-up capital is ₹3.60 Cr.
The compliance status of Umedica Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX